keyword
https://read.qxmd.com/read/38647391/magnetic-nanoparticle-assisted-non-viral-crispr-cas9-for-enhanced-genome-editing-to-treat-rett-syndrome
#1
JOURNAL ARTICLE
Hyeon-Yeol Cho, Myungsik Yoo, Thanapat Pongkulapa, Hudifah Rabie, Alysson R Muotri, Perry T Yin, Jeong-Woo Choi, Ki-Bum Lee
The CRISPR-Cas9 technology has the potential to revolutionize the treatment of various diseases, including Rett syndrome, by enabling the correction of genes or mutations in human patient cells. However, several challenges need to be addressed before its widespread clinical application. These challenges include the low delivery efficiencies to target cells, the actual efficiency of the genome-editing process, and the precision with which the CRISPR-Cas system operates. Herein, the study presents a Magnetic Nanoparticle-Assisted Genome Editing (MAGE) platform, which significantly improves the transfection efficiency, biocompatibility, and genome-editing accuracy of CRISPR-Cas9 technology...
April 22, 2024: Advanced Science (Weinheim, Baden-Wurttemberg, Germany)
https://read.qxmd.com/read/38646933/phototoxicity-avoidance-is-a-potential-therapeutic-approach-for-retinal-dystrophy-caused-by-eys-dysfunction
#2
JOURNAL ARTICLE
Yuki Otsuka, Keiko Imamura, Akio Oishi, Kazuhide Asakawa, Takayuki Kondo, Risako Nakai, Mika Suga, Ikuyo Inoue, Yukako Sagara, Kayoko Tsukita, Kaori Teranaka, Yu Nishimura, Akira Watanabe, Kazuhiro Umeyama, Nanako Okushima, Kohnosuke Mitani, Hiroshi Nagashima, Koichi Kawakami, Keiko Muguruma, Akitaka Tsujikawa, Haruhisa Inoue
Inherited retinal dystrophies (IRDs) are progressive diseases leading to vision loss. Mutation in the eyes shut homolog (EYS) gene is one of the most frequent causes of IRD. However, the mechanism of photoreceptor cell degeneration by mutant EYS has not been fully elucidated. Here, we generated retinal organoids from induced pluripotent stem cells (iPSCs) derived from patients with EYS-associated retinal dystrophy (EYS-RD). In photoreceptor cells of RD organoids, both EYS and G protein-coupled receptor kinase 7 (GRK7), one of the proteins handling phototoxicity, were not in the outer segment, where they are physiologically present...
April 22, 2024: JCI Insight
https://read.qxmd.com/read/38645248/activation-of-hypoactive-parvalbumin-positive-fast-spiking-interneuron-restores-dentate-inhibition-to-prevent-epileptiform-activity-in-the-mouse-intrahippocampal-kainate-model-of-temporal-lobe-epilepsy
#3
Sang-Hun Lee, Young-Jin Kang, Bret N Smith
UNLABELLED: Parvalbumin-positive (PV+) GABAergic interneurons in the dentate gyrus provide powerful perisomatic inhibition of dentate granule cells (DGCs) to prevent overexcitation and maintain the stability of dentate gyrus circuits. Most dentate PV+ interneurons survive status epilepticus, but surviving PV+ interneuron mediated inhibition is compromised in the dentate gyrus shortly after status epilepticus, contributing to epileptogenesis in temporal lobe epilepsy. It is uncertain whether the impaired activity of dentate PV+ interneurons recovers at later times or if it continues for months following status epilepticus...
April 8, 2024: bioRxiv
https://read.qxmd.com/read/38644687/primary-mitochondrial-diseases-the-intertwined-pathophysiology-of-bioenergetic-dysregulation-oxidative-stress-and-neuroinflammation
#4
REVIEW
Kevin Aguilar, Patrycja Jakubek, Antonio Zorzano, Mariusz R Wieckowski
OBJECTIVES AND SCOPE: Primary mitochondrial diseases (PMDs) are rare genetic disorders resulting from mutations in genes crucial for effective oxidative phosphorylation (OXPHOS) that can affect mitochondrial function. In this review, we examine the bioenergetic alterations and oxidative stress observed in cellular models of primary mitochondrial diseases (PMDs), shedding light on the intricate complexity between mitochondrial dysfunction and cellular pathology. We explore the diverse cellular models utilized to study PMDs, including patient-derived fibroblasts, induced pluripotent stem cells (iPSCs) and cybrids...
April 21, 2024: European Journal of Clinical Investigation
https://read.qxmd.com/read/38643173/exosomal-mir-9-5p-derived-from-ipsc-mscs-ameliorates-doxorubicin-induced-cardiomyopathy-by-inhibiting-cardiomyocyte-senescence
#5
JOURNAL ARTICLE
Huifeng Zheng, Xiaoting Liang, Baojuan Liu, Xinran Huang, Ying Shen, Fang Lin, Jiaqi Chen, Xiaoyan Gao, Haiwei He, Weifeng Li, Bei Hu, Xin Li, Yuelin Zhang
Doxorubicin (DOX) is a chemotherapeutic agent widely used for tumor treatment. Nonetheless its clinical application is heavily limited by its cardiotoxicity. There is accumulated evidence that transplantation of mesenchymal stem cell-derived exosomes (MSC-EXOs) can protect against Dox-induced cardiomyopathy (DIC). This study aimed to examine the cardioprotective effects of EXOs isolated from human induced pluripotent stem cell-derived MSCs (iPSC-MSCs) against DIC and explore the potential mechanisms. EXOs were isolated from the cultural supernatant of human BM-MSCs (BM-MSC-EXOs) and iPSC-MSCs (iPSC-MSC-EXOs) by ultracentrifugation...
April 20, 2024: Journal of Nanobiotechnology
https://read.qxmd.com/read/38642558/generation-of-human-alveolar-epithelial-type-i-cells-from-pluripotent-stem-cells
#6
JOURNAL ARTICLE
Claire L Burgess, Jessie Huang, Pushpinder S Bawa, Konstantinos-Dionysios Alysandratos, Kasey Minakin, Lauren J Ayers, Michael P Morley, Apoorva Babu, Carlos Villacorta-Martin, Maria Yampolskaya, Anne Hinds, Bibek R Thapa, Feiya Wang, Adeline Matschulat, Pankaj Mehta, Edward E Morrisey, Xaralabos Varelas, Darrell N Kotton
Alveolar epithelial type I cells (AT1s) line the gas exchange barrier of the distal lung and have been historically challenging to isolate or maintain in cell culture. Here, we engineer a human in vitro AT1 model system via directed differentiation of induced pluripotent stem cells (iPSCs). We use primary adult AT1 global transcriptomes to suggest benchmarks and pathways, such as Hippo-LATS-YAP/TAZ signaling, enriched in these cells. Next, we generate iPSC-derived alveolar epithelial type II cells (AT2s) and find that nuclear YAP signaling is sufficient to promote a broad transcriptomic shift from AT2 to AT1 gene programs...
April 15, 2024: Cell Stem Cell
https://read.qxmd.com/read/38642550/myosin-inhibitor-reverses-hypertrophic-cardiomyopathy-in-genotypically-diverse-pediatric-ipsc-cardiomyocytes-to-mirror-variant-correction
#7
JOURNAL ARTICLE
Caroline Kinnear, Abdelrahman Said, Guoliang Meng, Yimu Zhao, Erika Y Wang, Naimeh Rafatian, Neha Parmar, Wei Wei, Filio Billia, Craig A Simmons, Milica Radisic, James Ellis, Seema Mital
Pathogenic variants in MYH7 and MYBPC3 account for the majority of hypertrophic cardiomyopathy (HCM). Targeted drugs like myosin ATPase inhibitors have not been evaluated in children. We generate patient and variant-corrected iPSC-cardiomyocytes (CMs) from pediatric HCM patients harboring single variants in MYH7 (V606M; R453C), MYBPC3 (G148R) or digenic variants (MYBPC3 P955fs, TNNI3 A157V). We also generate CMs harboring MYBPC3 mono- and biallelic variants using CRISPR editing of a healthy control. Compared with isogenic and healthy controls, variant-positive CMs show sarcomere disorganization, higher contractility, calcium transients, and ATPase activity...
April 16, 2024: Cell reports medicine
https://read.qxmd.com/read/38642274/from-stem-cells-to-pancreatic-%C3%AE-cells-strategies-applications-and-potential-treatments-for-diabetes
#8
REVIEW
Xingrong Feng, Hongmei Zhang, Shanshan Yang, Daxin Cui, Yanting Wu, Xiaocun Qi, Zhiguang Su
Loss and functional failure of pancreatic β-cells results in disruption of glucose homeostasis and progression of diabetes. Although whole pancreas or pancreatic islet transplantation serves as a promising approach for β-cell replenishment and diabetes therapy, the severe scarcity of donor islets makes it unattainable for most diabetic patients. Stem cells, particularly induced pluripotent stem cells (iPSCs), are promising for the treatment of diabetes owing to their self-renewal capacity and ability to differentiate into functional β-cells...
April 20, 2024: Molecular and Cellular Biochemistry
https://read.qxmd.com/read/38641924/variant-specific-effects-of-gba1-mutations-on-dopaminergic-neuron-proteostasis
#9
JOURNAL ARTICLE
G Onal, G Yalçın-Çakmaklı, C E Özçelik, I Boussaad, U Ö Ş Şeker, Hugo J R Fernandes, H Demir, R Krüger, B Elibol, S Dökmeci, M M Salman
Glucocerebrosidase 1 (GBA1) mutations are the most important genetic risk factors for Parkinson's disease (PD). Clinically, mild (e.g., p.N370S) and severe (e.g., p.L444P and p.D409H) GBA1 mutations have different PD phenotypes, with differences in age at disease onset, progression, and the severity of motor and non-motor symptoms. We hypothesize that GBA1 mutations cause the accumulation of α-synuclein by affecting the cross-talk between cellular protein degradation mechanisms, leading to neurodegeneration...
April 20, 2024: Journal of Neurochemistry
https://read.qxmd.com/read/38640637/generation-of-an-induced-pluripotent-stem-cell-line-sjtughi003-a-from-a-patient-with-sorsby-fundus-dystrophy-carrying-c-484g-a-mutation-in-timp3-gene
#10
JOURNAL ARTICLE
Xinyue Zhu, Lu Tang, Ting Zhang, Xinyue Bai, Jieqiong Chen, Lei Zhang, Yuanyuan Gong, Mei Jiang, Xiaodong Sun
Sorsby fundus dystrophy (SFD) is a rare autosomal dominant disorder with macular dystrophy and severe visual loss. Mutations in TIMP3 gene has been related to SFD with mechanisms unclear. We have successfully reprogrammed the peripheral blood mononuclear cells (PBMCs) from an SFD patient carrying c.484G>A mutation in TIMP3 gene to induced pluripotent stem cells (iPSCs) and characterized their pluripotency and genetic stability. This line may serve as a useful tool to explore the role of TIMP3 in SFD pathogenesis...
April 17, 2024: Stem Cell Research
https://read.qxmd.com/read/38640063/macrophage-memories-of-early-life-injury-drive-neonatal-nociceptive-priming
#11
JOURNAL ARTICLE
Adam J Dourson, Adewale O Fadaka, Anna M Warshak, Aditi Paranjpe, Benjamin Weinhaus, Luis F Queme, Megan C Hofmann, Heather M Evans, Omer A Donmez, Carmy Forney, Matthew T Weirauch, Leah C Kottyan, Daniel Lucas, George S Deepe, Michael P Jankowski
The developing peripheral nervous and immune systems are functionally distinct from those of adults. These systems are vulnerable to early-life injury, which influences outcomes related to nociception following subsequent injury later in life (i.e., "neonatal nociceptive priming"). The underpinnings of this phenomenon are unclear, although previous work indicates that macrophages are trained by inflammation and injury. Our findings show that macrophages are both necessary and partially sufficient to drive neonatal nociceptive priming, possibly due to a long-lasting remodeling in chromatin structure...
April 18, 2024: Cell Reports
https://read.qxmd.com/read/38639829/replacing-animal-testing-with-stem-cell-organoids-advantages-and-limitations
#12
REVIEW
Guiyoung Park, Yeri Alice Rim, Yeowon Sohn, Yoojun Nam, Ji Hyeon Ju
Various groups including animal protection organizations, medical organizations, research centers, and even federal agencies such as the U.S. Food and Drug Administration, are working to minimize animal use in scientific experiments. This movement primarily stems from animal welfare and ethical concerns. However, recent advances in technology and new studies in medicine have contributed to an increase in animal experiments throughout the years. With the rapid increase in animal testing, concerns arise including ethical issues, high cost, complex procedures, and potential inaccuracies...
April 19, 2024: Stem cell reviews and reports
https://read.qxmd.com/read/38638602/mutations-in-the-postsynaptic-density-signaling-hub-tnik-disrupt-psd-signaling-in-human-models-of-neurodevelopmental-disorders
#13
JOURNAL ARTICLE
Jianzhi Jiang, Brent Wilkinson, Ilse Flores, Nicolas Hartel, Simeon R Mihaylov, Veronica A Clementel, Helen R Flynn, Fowsan S Alkuraya, Sila Ultanir, Nicholas A Graham, Marcelo P Coba
A large number of synaptic proteins have been recurrently associated with complex brain disorders. One of these proteins, the Traf and Nck interacting kinase (TNIK), is a postsynaptic density (PSD) signaling hub, with many variants reported in neurodevelopmental disorder (NDD) and psychiatric disease. While rodent models of TNIK dysfunction have abnormal spontaneous synaptic activity and cognitive impairment, the role of mutations found in patients with TNIK protein deficiency and TNIK protein kinase activity during early stages of neuronal and synapse development has not been characterized...
2024: Frontiers in Molecular Neuroscience
https://read.qxmd.com/read/38638299/abnormal-cell-sorting-and-altered-early-neurogenesis-in-a-human-cortical-organoid-model-of-protocadherin-19-clustering-epilepsy
#14
JOURNAL ARTICLE
Wei Niu, Lu Deng, Sandra P Mojica-Perez, Andrew M Tidball, Roksolana Sudyk, Kyle Stokes, Jack M Parent
INTRODUCTION: Protocadherin-19 ( PCDH19 )-Clustering Epilepsy (PCE) is a developmental and epileptic encephalopathy caused by loss-of-function variants of the PCDH19 gene on the X-chromosome. PCE affects females and mosaic males while male carriers are largely spared. Mosaic expression of the cell adhesion molecule PCDH19 due to random X-chromosome inactivation is thought to impair cell-cell interactions between mutant and wild type PCDH19 -expressing cells to produce the disease. Progress has been made in understanding PCE using rodent models or patient induced pluripotent stem cells (iPSCs)...
2024: Frontiers in Cellular Neuroscience
https://read.qxmd.com/read/38638145/altered-neuroepithelial-morphogenesis-and-migration-defects-in-ipsc-derived-cerebral-organoids-and-2d-neural-stem-cells-in-familial-bipolar-disorder
#15
JOURNAL ARTICLE
Kruttika Phalnikar, M Srividya, S V Mythri, N S Vasavi, Archisha Ganguly, Aparajita Kumar, Padmaja S, Kishan Kalia, Srishti S Mishra, Sreeja Kumari Dhanya, Pradip Paul, Bharath Holla, Suhas Ganesh, Puli Chandramouli Reddy, Reeteka Sud, Biju Viswanath, Bhavana Muralidharan
Bipolar disorder (BD) is a severe mental illness that can result from neurodevelopmental aberrations, particularly in familial BD, which may include causative genetic variants. In the present study, we derived cortical organoids from BD patients and healthy (control) individuals from a clinically dense family in the Indian population. Our data reveal that the patient organoids show neurodevelopmental anomalies, including organisational, proliferation and migration defects. The BD organoids show a reduction in both the number of neuroepithelial buds/cortical rosettes and the ventricular zone size...
2024: Oxf Open Neurosci
https://read.qxmd.com/read/38637847/cell-specific-extracellular-vesicle-encapsulated-exogenous-gaba-controls-seizures-in-epilepsy
#16
JOURNAL ARTICLE
Abhijna Ballal R, Shivakumar Reddy K, Divya Chandran, Sumukha Hegde, Raghavendra Upadhya, Praveen Kumar Se, Smita Shenoy, Vasudha Devi, Dinesh Upadhya
BACKGROUND: Epilepsy affects ∼60 million people worldwide. Most antiseizure medications in the market act on voltage-gated sodium or calcium channels, indirectly modulating neurotransmitter GABA or glutamate levels or multiple targets. Earlier studies made significant efforts to directly deliver GABA into the brain with varied success. Herein, we have hypothesized to directly deliver exogenous GABA to the brain with epilepsy through extracellular vesicles (EVs) from human GABA-producing cells and their progenitors as EVs largely mimic their parent cell composition...
April 19, 2024: Stem Cell Research & Therapy
https://read.qxmd.com/read/38637837/genome-editing-ipsc-to-purposing-enhancement-of-induce-cd8-killer-t-cell-function-for-regenerative-immunotherapy
#17
REVIEW
Sota Kurihara, Akihiro Ishikawa, Shin Kaneko
In recent years, immunotherapy has become a standard cancer therapy, joining surgery, chemotherapy, and radiation therapy. This therapeutic approach involves the use of patient-derived antigen-specific T cells or genetically modified T cells engineered with chimeric antigen receptors (CAR) or T cell receptors (TCR) that specifically target cancer antigens. However, T cells require ex vivo stimulation for proliferation when used in therapy, and the resulting "exhaustion," which is characterized by a diminished proliferation capacity and anti-tumor activity, poses a significant challenge...
April 18, 2024: Inflammation and Regeneration
https://read.qxmd.com/read/38636268/efficient-generation-of-induced-pluripotent-stem-cell-lines-from-healthy-donors-peripheral-blood-mononuclear-cells-of-different-genders
#18
JOURNAL ARTICLE
Yunfeng Gao, Yanhong Cheng, Bao Lin, Dan Xiao, Junjie Wen, Jingyu Xu, Ran Zheng, Mengna Zhang, Cheguo Cai, Junyuan Hu
Peripheral blood mononuclear cell (PBMC) are recognized as a conveniently collected reprogramming resource. Several methods are available in academia to reprogram PBMC into induced pluripotent stem cells (iPSC). In this research, we reprogrammed PBMC of different genders by using non-integrative non-viral liposome electrotransfer containing the reprogramming factors OCT4, SOX2, KLF4, and c-MYC. The three obtained iPSC cell lines were karyotypically normal and showed significant tritiated differentiation potential in vitro and in vivo...
April 15, 2024: Stem Cell Research
https://read.qxmd.com/read/38635773/mitochondrial-trna-pseudouridylation-governs-erythropoiesis
#19
JOURNAL ARTICLE
Bichen Wang, Deyang Shi, Shuang Yang, Yu Lian, Haoyuan Li, Mutian Cao, Yifei He, Lele Zhang, Chen Qiu, Tong Liu, Wei Wen, Yuanwu Ma, Lei Shi, Tao Cheng, Lihong Shi, Weiping Yuan, Yajing Chu, Jun Shi
Pseudouridine is the most prevalent RNA modification, and its aberrant function is implicated in various human diseases. However, the specific impact of pseudouridylation on hematopoiesis remains poorly understood. In this study, we investigated the role of tRNA pseudouridylation in erythropoiesis and its association with mitochondrial myopathy, lactic acidosis, and sideroblastic anemia syndrome (MLASA) pathogenesis. By utilizing patient-specific induced pluripotent stem cells (iPSCs) carrying a genetic PUS1 mutation and a corresponding mutant mouse model, we demonstrated impaired erythropoiesis in MLASA iPSCs and anemia in the MLASA mouse model...
April 18, 2024: Blood
https://read.qxmd.com/read/38635628/parkinsonism-sac-domain-mutation-in-synaptojanin-1-affects-ciliary-properties-in-ipsc-derived-dopaminergic-neurons
#20
JOURNAL ARTICLE
Nisha Mohd Rafiq, Kenshiro Fujise, Martin Shaun Rosenfeld, Peng Xu, Pietro De Camilli
Synaptojanin-1 (SJ1) is a major neuronal-enriched PI(4, 5)P2 4- and 5-phosphatase implicated in the shedding of endocytic factors during endocytosis. A mutation (R258Q) that impairs selectively its 4-phosphatase activity causes Parkinsonism in humans and neurological defects in mice (SJ1RQ KI mice). Studies of these mice showed, besides an abnormal assembly state of endocytic factors at synapses, the presence of dystrophic nerve terminals selectively in a subset of nigro-striatal dopamine (DA)-ergic axons, suggesting a special lability of DA neurons to the impairment of SJ1 function...
April 23, 2024: Proceedings of the National Academy of Sciences of the United States of America
keyword
keyword
42156
1
2
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.